Fritextsökning
Innehållstyper
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Sju medicinbolag med på topplista
Skräddarsydda antikroppar, blodtest och webbaserad patientrekrytering med på topp 33-lista över heta teknikbolag.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB
Why are you going to Scanlab+Biotech Forum?
-
Steven Burrill vill starta svensk fond
Investeraren och analytikern Steven Burrill var nyligen i Sverige för besluta om han ska starta en svensk eller nordisk life science-fond. - Det finns mycket st...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Young, bright and committed to labtech
Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Urvattnat sjukvårdsförslag i USA
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Infektion på agendan i Umeå
Richard Bergström, Efpia, och Charlotte Edlund från Läkemedelsverket diskuterade de regulatoriska kraven för nya antibiotika på en konferens i Umeå.
-
Sverige populärast på BIO2009
Rekordmånga besökare kom for att höra Jonas Frisén från Karolinska Institutet berätta om svensk stamcellsforskning.
-
Standard-inkubation inget för life science-projekt
Svenska life science-projekt behöver alternativa vägar ut på marknaden...
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Hårdare krav på godkännanden i EU än i USA?
-
"Det krävs mer än pengar för att bli en framstående nation inom life science"
Debatt: Det krävs en helhetssyn av ett läkemedels hela livscykel för att uppfylla regeringens mål att med forskning och innovation och därför startar Läkemedels...
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.